Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Arteriosclerosis D001161 86 associated lipids
Body Weight D001835 333 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Effect on hypertension and benign breast disease of progestagen component in combined oral contraceptives. 1977 Lancet pmid:66428
Zupon MA et al. In vivo release of norethindrone coupled to a biodegradable poly(alpha-amino acid) drug delivery system. 1983 J Pharm Sci pmid:6644595
Beck LR et al. Clinical evaluation of an improved injectable microcapsule contraceptive system. 1983 Am. J. Obstet. Gynecol. pmid:6650605
Brozman M et al. [Cardiomyopathy with hepatic necrosis after several years of using Norbiogest Spofa]. 1983 Bratisl Lek Listy pmid:6652532
Crabbé P et al. Long-acting contraceptive agents: design of the WHO Chemical Synthesis Programme. 1983 Steroids pmid:6658872
Watson TG et al. Long-acting contraceptive agents: esters of norethisterone with alpha- and/or beta-chain branching. 1983 Steroids pmid:6658873
Francisco CG et al. Long-acting contraceptive agents: norethisterone esters of monoalkenyl and monoalkynyl acids. 1983 Steroids pmid:6658874
Francisco CG et al. Long-acting contraceptive agents: norethisterone esters of polyunsaturated acids. 1983 Steroids pmid:6658875
Shafiee A et al. Long-acting contraceptive agents: esters of norethisterone with alkoxy- and halogeno-substituted carboxylic acids. 1983 Steroids pmid:6658876
Shafiee A et al. Long-acting contraceptive agents: cyclopropyl and cyclobutyl esters of norethisterone. 1983 Steroids pmid:6658877
Wan AS et al. Long-acting contraceptive agents: norethisterone esters of arylcarboxylic acids. 1983 Steroids pmid:6658878
Wan AS et al. Long-acting contraceptive agents: furylalkylcarboxylic acid esters of norethisterone. 1983 Steroids pmid:6658879
Herz JE and Sandoval J Long-acting contraceptive agents: bile acid esters of norethisterone. 1983 Steroids pmid:6658880
Herz JE et al. Long-acting contraceptive agents: carbonates and carbamates of norethisterone. 1983 Steroids pmid:6658881
Enever RP and Lewis GA Long-acting contraceptive agents: the influence of pharmaceutical formulation upon biological activity of esters of norethisterone. 1983 Steroids pmid:6658882
Enever RP et al. Long-acting contraceptive agents: the influence of physico-chemical properties of some esters of norethisterone upon the plasma levels of free norethisterone. 1983 Steroids pmid:6658883
Garza-Flores J et al. A rapid and sensitive radioimmunoassay for norethisterone. 1983 Steroids pmid:6665817
Watanabe H et al. HPLC-RIA of a metabolite of norethindrone in human plasma, 17 alpha-ethinyl-5 beta-estrane-3 alpha, 17 beta-diol, following conjugate hydrolysis. 1983 Contraception pmid:6667622
Osawa Y et al. Irreversible inhibitors of oestrogen biosynthesis (aromatase). 1983 Biochem. Soc. Trans. pmid:6667772
Nuzzo G et al. Rupture of multiple hepatic adenoma and oral contraceptive use: a case report. 1983 Ital J Surg Sci pmid:6671896
Fotherby K et al. Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive. 1983 Contraception pmid:6673900
Andolśek L et al. Influence of oral contraceptives on the incidence of premalignant and malignant lesions of the cervix. 1983 Contraception pmid:6673904
Huang L et al. [Studies on long acting contraceptives: synthesis of 17 beta-steroid esters]. 1983 Yao Xue Xue Bao pmid:6677029
Velasco Murillo V et al. [Use and effectiveness of norethisterone enanthate for family planning in a rural area]. 1983 Ginecol Obstet Mex pmid:6681299
McShane PM et al. Thrombotic thrombocytopenic purpura associated with oral contraceptives: a case report. 1983 Am. J. Obstet. Gynecol. pmid:6681940
Larrea F et al. [Mechanism of transport and interaction of norethisterone with plasma proteins]. 1983 Jul-Sep Rev. Invest. Clin. pmid:6685338
DiNunno CM et al. 7 alpha-Methylnorethindrone enanthate 10 beta-hydroperoxide: isolation and characterization. 1983 Steroids pmid:6689617
Durant RH et al. Influence of psychosocial factors on adolescent compliance with oral contraceptives. 1984 J Adolesc Health Care pmid:6693340
Jay MS et al. Effect of peer counselors on adolescent compliance in use of oral contraceptives. 1984 Pediatrics pmid:6694867
Templeton A et al. The recovery of pre-ovulatory oocytes using a fixed schedule of ovulation induction and follicle aspiration. 1984 Br J Obstet Gynaecol pmid:6696860
Hahn RG et al. Compliance difficulties with progestin-supplemented estrogen replacement therapy. 1984 J Fam Pract pmid:6699581
Kabarity A and Mazrooei S Further investigations on the cytological effects of some contraceptives. 1984 Mutat. Res. pmid:6708960
Gupta GN et al. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study. 1984 Fertil. Steril. pmid:6714449
Mills JL et al. Effects of occupational exposure to estrogen and progestogens and how to detect them. 1984 J Occup Med pmid:6716192
Coutinho EM et al. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol. 1984 Contraception pmid:6723313
Christiansen C et al. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment. 1984 Maturitas pmid:6727693
Kaiser R Duration of the climacteric syndrome in women treated by hormonal substitution and in controls. 1984 Maturitas pmid:6727694
Robertson MC A study of women on the progestogen only pill. 1984 Practitioner pmid:6728816
Schindler C and Rodriguez L [Comparative studies of the effect on the in vitro growth of endometrial cancers of hydroxyprogesterone caproate, norethisterone acetate and D-norgestrel]. 1984 Zentralbl Gynakol pmid:6730768
Back DJ et al. An investigation of the effects of phenobarbitone on the pharmacokinetics of norethindrone in the rat using liver perfusion and everted gut sacs. 1984 Biochem. Pharmacol. pmid:6732832
Earl HM et al. Norethisterone acetate in the treatment of advanced breast cancer. 1984 Clin Oncol pmid:6734001
Fink BJ Endometrial changes after long-term use of continuous oestrogen and cyclic progestogen. 1984 Maturitas pmid:6738374
Ho-Ngoc A et al. Quantitation of delta 4-reduced metabolite of norethindrone in human plasma by HPLC-RIA. 1984 Res. Commun. Chem. Pathol. Pharmacol. pmid:6739957
Walther Meade C et al. A clinical study of norethisterone enanthate in rural Mexico. 1984 May-Jun Stud Fam Plann pmid:6740731
Zachmann M et al. Influence of oestrogen in high and low doses on plasma steroid concentrations in girls with tall stature and Turner syndrome. 1984 Acta Endocrinol. pmid:6741400
Fotherby K et al. Pharmacokinetics of different doses of norethisterone oenanthate. 1984 Contraception pmid:6744856
Fotherby K et al. Return of ovulation and fertility in women using norethisterone oenanthate. 1984 Contraception pmid:6744861
Rivera R et al. The use of biodegradable norethisterone implants as a 6-month contraceptive system. 1984 Fertil. Steril. pmid:6745456
Paterson ME A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters. 1982 Maturitas pmid:6750325
Christensen MS et al. Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions. 1982 Am. J. Obstet. Gynecol. pmid:6756151
Graham S and Fraser IS The progestogen-only mini-pill. 1982 Contraception pmid:6759029
Fraser IS and Weisberg E Fertility following discontinuation of different methods of fertility control. 1982 Contraception pmid:6759030
Roy S et al. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. 1980 Am. J. Obstet. Gynecol. pmid:6767404
Tafurt CA et al. Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin. 1980 Fertil. Steril. pmid:6767626
Thom MH and Studd JW Procedures in practice. Hormone implantation. 1980 Br Med J pmid:6768415
Maitra A et al. Release of norethisterone from a bioabsorbable implant in female bonnet monkeys (Macaca radiata). 1980 Contraception pmid:6768491
Nishino Y and Neumann F [Estrogenic partial effect of gestagens, in particular that of norethisterone enanthate (author's transl)]. 1980 Arzneimittelforschung pmid:6770875
Breckwoldt M et al. Plasma levels of FSH and LH in patients with gonadal dysgenesis during sequential estrogen and progestogen therapy. 1980 Arch. Gynecol. pmid:6779717
Nuttal ID and Elstein M Steroid releasing vaginal rings. 1980 Acta Eur. Fertil. pmid:6781195
Melis GB et al. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women. 1981 Contraception pmid:6781816
Prasad KV et al. Effect of food restriction (undernutrition) on pharmacokinetics of norethindrone in rabbits. 1981 Contraception pmid:6781817
Andino N Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET). 1981 Contraception pmid:6786825
Laumas V et al. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone. 1981 Contraception pmid:6786828
Landgren BM et al. Hormonal effects of the 300 microgram norethisterone (NET) minipill. 3. Comparison of the short-term (2nd month) and medium-term (6th month) effects in 21 subjects. 1981 Contraception pmid:6786830
Pedrón N et al. [Comparative study of menstrual blood loss with progestagen-releasing intrauterine devices]. 1981 Ginecol Obstet Mex pmid:6791989
Briggs M and Briggs M A randomized study of metabolic effects of four low-estrogen oral contraceptives: I. Results after 6 cycles. 1981 Contraception pmid:6793298
Prasad KV et al. Effect of food restriction (undernutrition) on plasma sex hormone binding globulin (SHBG) capacity, liver drug metabolizing enzymes and uterine cytosol progesterone receptor levels in rabbits. 1981 Contraception pmid:6793302
Christiansen C et al. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. 1981 Eur. J. Clin. Invest. pmid:6795047
Jenkins N and Fotherby K Binding of the gestagens norethisterone and levonorgestrel in blood of various species. 1981 J. Steroid Biochem. pmid:6795390
Fotherby K et al. Plasma levels of norethisterone after single and multiple injections of norethisterone oenanthate. 1978 Contraception pmid:679682
Nuttall ID et al. The effect of norethisterone capsules on the pituitary-ovarian axis. 1982 Contraception pmid:6800692
Kay CR Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study. 1982 Am. J. Obstet. Gynecol. pmid:6801981
Wynn V and Niththyananthan R The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. 1982 Am. J. Obstet. Gynecol. pmid:6801982
Meade TW Effects of progestogens on the cardiovascular system. 1982 Am. J. Obstet. Gynecol. pmid:6801983
A randomized, double-blind study of six combined oral contraceptives. 1982 Contraception pmid:6804161
Sheth A et al. A randomized, double-blind study of two combined and two progestogen-only oral contraceptives. 1982 Contraception pmid:6804162
Ylöstalo P et al. Bromocriptine and norethisterone in the treatment of premenstrual syndrome. 1982 Obstet Gynecol pmid:6804900
Sheehan JP Hormone replacement treatment and benign intracranial hypertension. 1982 Br Med J (Clin Res Ed) pmid:6805652
Guivernau M et al. Estrogens induce lipoxygenase derivative formation in rabbit lens. 1982 Invest. Ophthalmol. Vis. Sci. pmid:6807937
Injectable hormonal contraceptives: technical and safety aspects. 1982 WHO Offset Publ pmid:6808784
Back DJ et al. The effects of ampicillin on oral contraceptive steroids in women. 1982 Br J Clin Pharmacol pmid:6809025
Kay CR Blood pressure and contraceptive use. 1982 Br Med J (Clin Res Ed) pmid:6809217
Nuttall ID et al. The effect of norethisterone (500 mcg) and ethinyl estradiol (35 mcg) capsules on the pituitary-ovarian axis. 1982 Contraception pmid:6809424
Weir RJ Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension. 1982 Scott Med J pmid:6810459
Silfverstolpe G et al. Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens. 1982 Maturitas pmid:6811837
Hagen C et al. Long-term effects of oestrogens in combination with gestagen on plasma prolactin and FSH levels in post-menopausal women. 1982 Acta Endocrinol. pmid:6812338
Hagen C et al. Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period. 1982 Acta Obstet Gynecol Scand pmid:6812385
Taga M et al. Synthesis and secretion of prolactin in the decidualized human endometrium unassociated with pregnancy in vitro. 1982 Endocrinol. Jpn. pmid:6816577
Robey-Lelièvre F and Ruet C [Long-term study of a progestational micropill: 600 mcg norethisterone acetate]. 1978 J Gynecol Obstet Biol Reprod (Paris) pmid:681702
Hardt W et al. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding]. 1982 Geburtshilfe Frauenheilkd pmid:6819180
Saint-Marc Girardin MF et al. Unilobar small hepatic vein obstruction: possible role of progestogen given as oral contraceptive. 1983 Gastroenterology pmid:6822331
Tamaya T et al. Nuclear translocation of progesterone receptor--progestogen complex in vitro. 1983 Nippon Sanka Fujinka Gakkai Zasshi pmid:6827166
Beck LR et al. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive. 1983 Biol. Reprod. pmid:6830939
Which I.U.D.? 1977 Lancet pmid:68335
Cheng DC and Wolfe BM Norethindrone acetate inhibition of triglyceride synthesis and release by rat hepatocytes. 1983 Atherosclerosis pmid:6838693
Dutkowski RT et al. The effect of oral contraceptives on sister chromatid exchange, blast transformation, mitotic index and micronuclei formation. 1983 Exp. Cell Biol. pmid:6840387
Altmayer P et al. Experiences with Norcolut (a new therapeutic gestagen). 1978 Ther Hung pmid:684654
Kiriwat O and Fotherby K Pharmacokinetics of oral contraceptive steroids after morning or evening administration. 1983 Contraception pmid:6851554
Pope VZ et al. The abortifacient effect of synthetic androstane derivatives in the baboon. 1983 Contraception pmid:6851556
Lox CD and Heine MW Interaction between ethanol and contraceptive steroids on clotting activity in the rat. 1983 Contraception pmid:6851568